HOME >> BIOLOGY >> NEWS
NIAID unveils bioterrorism research agenda

The National Institute of Allergy and Infectious Diseases (NIAID) today released the NIAID Counter-Bioterrorism Research Agenda for CDC Category A Agents, a document describing the Institute's accelerated research plan for the most threatening agents of bioterrorism. The agenda outlines the research NIAID will undertake to help protect civilian populations from diseases such as smallpox, anthrax and plague should they be unleashed intentionally by those who wish to do harm.

The comprehensive plan includes short-, intermediate- and long-term research goals and describes specifically how bioterrorism countermeasures will be developed for each microbe. The document also contains a copy of the Strategic Plan for Counter-Bioterrorism Research of the NIAID, which provides a general overview of the Institute's broad plans for attacking the full range of potential bioterrorism pathogens.

"Research is a vital element of bioterrorism defense," says HHS Secretary Tommy G. Thompson. "The NIAID Counter-Bioterrorism Research Agenda describes the highest priorities of an accelerated program to expand research on bioterrorism agents and to quickly develop new diagnostics, drugs and vaccines to protect the public."

The Research Agenda was developed by NIAID scientists and reviewed by an outside panel of experts from academia, industry and government in early February. The plan focuses on the Category A diseases as described by the Centers for Disease Control and Prevention (CDC): anthrax, smallpox, plague, tularemia, viral hemorrhagic fevers and botulism. Those diseases cause high death rates or serious illness, are relatively easy to spread, could cause public panic or require special steps for public health preparedness. NIAID plans to develop research plans for CDC Category B and C agents in the near future.

As the National Institutes of Health's lead institute on immunology and infectious diseases research, NIAID has made many key contribu
'"/>

Contact: Sam Perdue
sp189u@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
14-Mar-2002


Page: 1 2 3 4

Related biology news :

1. TIGR and NIAID sign $65 million microbial sequencing contract
2. NIAID takes next genome step
3. NIAID awards grant to rapidly sequence the malaria mosquito genome
4. NIAID launches major step in trial of experimental shingles vaccine
5. NIAID-Supported Scientists Discover Origin Of HIV-1
6. NIAID Scientists Discover HIV Disease-Slowing Mutation
7. NIAID Doctor Successfully Treats Longest Case Of Malaria Infection On Record
8. Pacific Northwest team unveils largest virus proteome to date
9. Pacific Northwest National Lab unveils most complete human blood-plasma proteome map to date
10. Department of Energys Office of Science unveils 20-year vision for the future of basic research
11. Ancient DNA analysis unveils mystery of historys most horribly deformed man -- The Elephant Man

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
(Date:4/4/2017)...   EyeLock LLC , a leader of iris-based ... Patent and Trademark Office (USPTO) has issued U.S. Patent ... an iris image with a face image acquired in ... 45 th issued patent. "The ... the multi-modal biometric capabilities that have recently come to ...
(Date:3/30/2017)... 2017  On April 6-7, 2017, Sequencing.com will host ... hackathon at Microsoft,s headquarters in Redmond, ... on developing health and wellness apps that provide a ... Genome is the first hackathon for personal genomics ... companies in the genomics, tech and health industries are ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... Lithuania, announced today that they have entered into a multiyear collaboration to identify ... CRISPR researchers with additional tools for gene editing across all applications. , Under ...
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces expanded coverage of ... newest module, US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats and ... synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates the market ...
(Date:10/12/2017)... Diego, CA (PRWEB) , ... ... ... (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform specifically ... all bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
Breaking Biology Technology:
Cached News: